FindMyKOL
Clinical trialNCT05411744Active, not recruitingPhase 4Interventional

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

SponsorRutgers, The State University of New JerseyEnrollment25End Stage Renal DiseaseLatent TuberculosisRenal Transplant Candidate for Left KidneyRenal Transplant Candidate for Right Kidney
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective, single-center, single-arm, open-label study investigating the safety, compliance and pharmacokinetics of 1-month treatment of Isoniazid, Rifapentine and Vitamin B6 in renal transplant candidates.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Pinki J Bhatt

    New Brunswick, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

1 month Rifapentine, Isoniazid and Vitamin B6
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2022
Primary completion
16 Jan 2026
Completion
30 Jun 2029
Last update posted
21 Jan 2026
Registered enrollment
25
Registry id
NCT05411744

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.